October 30, 2025

Summarizing the Big Events in the Small Molecules Field

October 2025 highlights in the small molecules sector include developments in dermatitis treatment, improvements in epilepsy symptoms, and the effects of amoxicillin availability.

The Medicine Maker

October 29, 2025

Linking Neurocognitive Outcomes and Advanced Techniques in Awake Glioma Surgery

Glioma surgery in eloquent brain regions remains one of the greatest challenges in neurosurgery, demanding a balance between oncologic control and preservation of function.

Baptist Health South Florida

October 28, 2025

Better Brain & Spine Care Through Clinical and Medical Research

Baptist Health South Florida advances healthcare through leading-edge clinical trials and research.

Baptist Health South Florida

October 15, 2025

This Week’s Biopharma News: Regulatory Concerns at Novo Nordisk plant

This week’s news roundup reports on AstraZeneca's deal with the US government, the challenges of off-patent antibiotics, gene therapy for hearing loss, and more.

The Medicine Maker

October 07, 2025

Nestor Beltre, M.D., Joins Baptist Health Miami Neuroscience Institute as a Neurologist

Board-certified neurologist Nestor Beltre, M.D., has joined Baptist Health Miami Neuroscience Institute.

Baptist Health South Florida

July 14, 2025

Robotic System Tested in Retinal Surgery

Early data from a first-in-human trial of the Luca robotic system for vitreoretinal surgery demonstrates that robotic assistance may improve surgical precision and reproducibility without compromising patient safety. Fanny Nerinckx, MD, presented the early results at the 2025 Retina World Congress in Fort Lauderdale, Florida. She described the study as an initial proof of concept that supports the feasibility of robotic vitreoretinal surgery using commercially available instruments.

Retinal Physician

April 01, 2025

Clinical Trial Update April 2025

Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.

Retinal Physician

October 01, 2025

Biomarkers May Help Quest for a Link Between Apnea and Alzheimer's

Links between obstructive sleep apnea and Alzheimer’s disease (AD) have long been thought to exist, but the long time horizon for Alzheimer's has been a barrier to investigation. Mount Sinai has now launched a study to assess whether patients who are successfully treated for obstructive sleep apnea demonstrate a slower decline in cognitive function and lower levels of plasma AD biomarkers compared to those who are untreated.

Mount Sinai New York

July 01, 2020

A Practical Guide to Herpes Zoster

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

Corneal Physician